← Return to Pancreatic tumor genotype KRAS G12c, removed but one node positive
DiscussionPancreatic tumor genotype KRAS G12c, removed but one node positive
Pancreatic Cancer | Last Active: Jun 5, 2022 | Replies (5)Comment receiving replies
Replies to "Have you actually submitted requests to join trials that have been rejected? We have found that..."
Thank for your inquiry. I have been in one trial with an immunotherapy and responded for 6 weeks but then became resistant. Two other studies were identified but both cut me out last minute, one due to too many treatments with other agents; the other because I had been treated with the immunotherapeutic. Of course we will try anything to try and hit a winner but the pharmas/researchers are targeting approval first. They really need to add arms for compassionate administration.